Skip to main content
Shaperon Inc. logo

Shaperon Inc. — Investor Relations & Filings

Ticker · 378800 ISIN · KR7378800007 KO Manufacturing
Open in API
Filings indexed 146 across all filing types
Latest filing 2025-09-16 Capital/Financing Update
Country KR South Korea
Listing KO 378800

About Shaperon Inc.

https://www.shaperon.com/

Shaperon Inc. is a clinical-stage biotechnology company that develops novel immune therapeutics for inflammatory diseases. The company's primary focus is on the development of innovative inflammasome inhibitors. Its core technology is based on a unique mechanism that modulates the GPCR19-P2X7 pathway to regulate the initiation and progression of inflammatory responses. This approach is applied to a pipeline of drug candidates targeting various inflammation-driven conditions.

Recent filings

Filing Released Lang Actions
투자설명서
Capital/Financing Update Classification · 95% confidence The document is a '투자설명서' (Investment Prospectus) issued by '주식회사 샤페론' (Chaperon Inc.) on September 16, 2025. It details a capital increase (rights offering/public offering) of 16,100,000 common shares. It contains comprehensive information regarding the offering, including subscription periods, payment dates, and detailed risk factors (business and financial risks). This document is a formal regulatory filing for a securities offering, which falls under the 'Proxy Solicitation & Information Statement' category in the provided schema, as it serves to inform shareholders and potential investors about the offering and solicit participation.
2025-09-16 Korean
권리락 (유상증자)
Share Issue/Capital Change Classification · 100% confidence The document is a short announcement regarding a 'rights offering' (유상증자) and the resulting 'ex-rights' (권리락) date for the company Shaperon. It provides specific details on the stock code, reference price, and the effective date of the ex-rights. This falls under the category of capital changes and share issuance announcements.
2025-09-16 Korean
임원ㆍ주요주주특정증권등거래계획보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Trading Plan for Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주특정증권등거래계획보고서) filed by an executive of the company 'Chaperon'. This is a regulatory filing required by the Financial Services Commission and the Korea Exchange regarding planned insider transactions. While it involves an executive, it is specifically a 'Trading Plan' report rather than a simple 'Director's Dealing' (which usually reports completed trades). Given the specific nature of this regulatory disclosure regarding future trading plans, it falls under the 'Regulatory Filings' category as it does not fit perfectly into the 'Director's Dealing' (which is for past trades) or other specific categories.
2025-09-12 Korean
[기재정정]증권신고서(지분증권) (2025.10)
Capital/Financing Update Classification · 95% confidence The document is a 'Securities Registration Statement (Amendment)' (증권신고서 정정신고) filed by Chaperon Co., Ltd. It details specific amendments to a previously filed securities registration statement, including updates to investment risk factors, financial stability indicators, and management's outlook. This type of filing is a formal regulatory document submitted to the financial authorities to correct or update information regarding a public offering or capital raise. It does not fit into categories like 'Annual Report' (10-K) or 'Earnings Release' (ER), but rather falls under the broader category of regulatory filings related to capital issuance.
2025-09-01 Korean
주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) regarding a 'Decision on Paid-in Capital Increase' (유상증자결정) for the company Shaperon. It details the issuance of new shares, pricing methods, subscription dates, and allocation procedures. This type of regulatory filing in the Korean market is a formal announcement of a capital change/share issuance, which falls under the 'Share Issue/Capital Change' category.
2025-08-18 Korean
증권신고서(지분증권) (2025.10)
Share Issue/Capital Change Classification · 95% confidence The document is a '증권신고서' (Securities Registration Statement) filed with the Financial Services Commission (FSC) in South Korea. It details a capital increase (유상증자) of 16,100,000 shares, outlines investment risks, financial status, and the purpose of the capital raise. This is a formal regulatory filing for a public offering of securities, which falls under the 'POS' (Transaction in Own Shares/Capital Change) or 'SHA' (Share Issue/Capital Change) category. Given the context of a formal registration statement for a new share issuance, 'SHA' is the most accurate classification.
2025-08-18 Korean

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.